Latest Articles
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery - Monash University
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery Monash University
Published: Sept. 9, 2026, 11:29 a.m.
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery - monash.edu
New non-hormonal therapy for endometriosis wins MedChem Australia funding to fast-track drug discovery monash.edu
Published: Sept. 9, 2026, 11:29 a.m.
Why sex matters in preclinical research - Drug Discovery News
Why sex matters in preclinical research Drug Discovery News
Published: Aug. 10, 2026, 6:52 p.m.
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - Business Wire
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery Business Wire
Published: Aug. 6, 2026, 10:30 a.m.
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery - businesswire.com
Opal Therapeutics Secures $1.25M NSF SBIR Phase II Award to Accelerate Women’s Health Drug Discovery businesswire.com
Published: Aug. 6, 2026, 10:30 a.m.
Exploring New Treatment Strategies for Endometriosis-Narrative Review.
The pharmacological treatment of endometriosis using SPRMs requires improvement. The pure PR-agonist dienogest (DNG), a clinically established progestin, can serve as a reference compound for comparison. Its efficacy and safety …
Published: July 28, 2026, midnight
Antibody therapy points to a new treatment era for primary membranous nephropathy - Drug Discovery News
Antibody therapy points to a new treatment era for primary membranous nephropathy Drug Discovery News
Published: June 16, 2026, 9:19 p.m.
FDA’s drug repurposing initiative signals renewed focus - Drug Discovery News
FDA’s drug repurposing initiative signals renewed focus Drug Discovery News
Published: June 10, 2026, 6:26 p.m.
An AI model decodes tumor mutations to predict treatment response - Drug Discovery News
An AI model decodes tumor mutations to predict treatment response Drug Discovery News
Published: June 1, 2026, 7:29 p.m.
Why 2026 could be a turning point for patient-focused trials - Drug Discovery News
Why 2026 could be a turning point for patient-focused trials Drug Discovery News
Published: May 28, 2026, 12:56 p.m.
Link copied to clipboard!